A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients

References

• Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet (London, England). 2014 Dec 6;384(9959):2053–2063.
   PubMed Web of Science ®Google Scholar
• Revill PA, Chisari FV, Block JM, et al. A global scientific strategy to cure hepatitis B. The Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545–558.
   PubMed Web of Science ®Google Scholar
• Lucifora J, Xia Y, Reisinger F, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science (New York, NY). 2014 Mar 14;343(6176):1221–1228.
   Google Scholar
• Wang J, Shen T, Huang X, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol. 2016 Oct;65(4):700–710.
   PubMed Web of Science ®Google Scholar
• Jansen L, Kootstra NA, van Dort KA, et al. Hepatitis b virus pregenomic RNA Is present in Virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos(t)ide analogues. J Infect Dis. 2016 Jan 15;213(2):224–232.
   PubMed Web of Science ®Google Scholar
• Bai L, Zhang X, Kozlowski M, et al. Extracellular Hepatitis B virus RNAs are heterogeneous in length and circulate as capsid-antibody complexes in addition to Virions in chronic Hepatitis B patients. J Virol. 2018 Dec 15;92(24):e00798.
   PubMed Web of Science ®Google Scholar
• Prakash K, Rydell GE, Larsson SB, et al. High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles. Virol J. 2018 May 15;15(1):86.
   PubMed Web of Science ®Google Scholar
• Shen S, Xie Z, Cai D, et al. Biogenesis and molecular characteristics of serum hepatitis B virus RNA. PLoS Pathog. 2020 Oct;16(10):e1008945.
   PubMed Web of Science ®Google Scholar
• Stadelmayer B, Diederichs A, Chapus F, et al. Full-length 5'RACE identifies all major HBV transcripts in HBV-infected hepatocytes and patient serum. J Hepatol. 2020 Jul;73(1):40–51.
   PubMed Web of Science ®Google Scholar
• Huang H, Wang J, Li W, et al. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals. Journal of Clin Virol: The Off Publ Pan Amen Soc Clin Virol. 2018 Feb-Mar;99-100:71–78.
   Web of Science ®Google Scholar
• Giersch K, Allweiss L, Volz T, et al. Serum HBV pgRNA as a clinical marker for cccDNA activity. J Hepatol. 2017 Feb;66(2):460–462.
   PubMed Web of Science ®Google Scholar
• Butler EK, Gersch J, McNamara A, et al. Hepatitis b virus serum DNA andRNA levels in nucleos(t)ide analog-treated or untreated patients during chronic and acute infection. Hepatology. 2018 Dec;68(6):2106–2117.
   PubMed Web of Science ®Google Scholar
• Huang Q, Zhou B, Cai D, et al. Rapid turnover of Hepatitis B virus covalently closed circular DNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic Hepatitis B patients. Hepatology. 2021 Jan;73(1):41–52.
   PubMed Web of Science ®Google Scholar
• Mak LY, Cloherty G, Wong DK, et al. HBV RNA profiles in chronic hepatitis B patients under different disease phases and anti-viral therapy. Hepatology. 2020 Nov 6;73(6):2167–2179.
   Web of Science ®Google Scholar
• van Bömmel F, Bartens A, Mysickova A, et al. Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors. Hepatology. 2015 Jan;61(1):66–76.
   PubMed Web of Science ®Google Scholar
• Luo H, Tan N, Kang Q, et al. Hepatitis B virus pregenomic RNA status can reveal the long-term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues. J Viral Hepat. 2020 Mar;27(3):323–328.
   PubMed Web of Science ®Google Scholar
• Farag MS, van Campenhout MJH, Pfefferkorn M, et al. Hepatitis b virus RNA as early predictor for response to PEGylated interferon Alfa in HBeAg Negative chronic Hepatitis B. Clin Infect Dis: An Off Publ Infect Dis Soc America. 2020 Jan 8;72(2):202–211.
   Web of Science ®Google Scholar
• Zhang M, Li G, Shang J, et al. Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study. Hepatol Int. 2020 Mar;14(2):212–224.
   PubMed Web of Science ®Google Scholar
• van Campenhout MJH, van Bömmel F, Pfefferkorn M, et al. Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis B. J Viral Hepat. 2020 Jun;27(6):610–619.
   PubMed Web of Science ®Google Scholar
• Lin N, Ye A, Lin J, et al. Diagnostic value of detection of pregenomic RNA in sera of Hepatitis B virus-infected patients with different clinical outcomes. J Clin Microbiol. 2020 Jan 28;58(2):e01275-19.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen X, Wu Y, et al. Serum HBV RNA is a potential predictor of Hepatitis B surface Antigen reversion. Hepatol Commun. 2018 Oct;2(10):1168–1171.
   PubMed Web of Science ®Google Scholar
• Fan R, Zhou B, Xu M, et al. Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy. Clin Gastroenterol Hepatol: The Off Clin Pract J Amen Gastroenterol Assoc. 2020 Mar;18(3):719–727. e7.
   PubMed Web of Science ®Google Scholar
• Fan R, Peng J, Xie Q, et al. Combining Hepatitis B virus RNA and Hepatitis B core-related antigen: Guidance for safely stopping nucleos(t)ide analogues in Hepatitis B e antigen-positive patients With chronic Hepatitis B. J Infect Dis. 2020 Jul 23;222(4):611–618.
   PubMed Web of Science ®Google Scholar
• Carey I, Gersch J, Wang B, et al. Pregenomic HBV RNA and Hepatitis B core-related antigen predict outcomes in Hepatitis B e antigen-negative chronic Hepatitis B patients suppressed on nucleos(T)ide analogue therapy. Hepatology. 2020 Jul;72(1):42–57.
   PubMed Web of Science ®Google Scholar
• Lam AM, Ren S, Espiritu C, et al. Hepatitis b virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants. Antimicrob Agents Chemother. 2017 Aug;61(8):e00680-17.
   PubMed Web of Science ®Google Scholar
• Wang J, Sheng Q, Ding Y, et al. HBV RNA virion-like particles produced under nucleos(t)ide analogues treatment are mainly replication-deficient. J Hepatol. 2018 Apr;68(4):847–849;76(1):234–236.
   PubMed Web of Science ®Google Scholar
• Guan G, Zou J, Zhang T, et al. A global survey of alternative splicing of HBV transcriptome using long-read sequencing. J Hepatol. 2021 Jul 29;76(1):234–236.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu H, Hu Z, et al. Hepatitis b virus Virions produced under nucleos(t)ide analogue treatment are mainly not infectious because of irreversible DNA chain termination. Hepatology. 2020 Feb;71(2):463–476.
   PubMed Web of Science ®Google Scholar
• Cornberg M, Lok AS-F, Terrault NA, et al. Guidance for design and endpoints of clinical trials in chronic hepatitis B - report from the 2019 EASL-AASLD HBV Treatment Endpoints conference‡. J Hepatol. 2020 2020/03/01/;72(3):539–557.
   PubMed Web of Science ®Google Scholar
• Patel N, White SJ, Thompson RF, et al. HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly. Nature Microbiol. 2017 Jun 19;2:17098.
   PubMed Web of Science ®Google Scholar
• Qi Z, Li G, Hu H, et al. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice. J Virol. 2014 Jul;88(14):8045–8056.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu F, Guo F, et al. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors. Antiviral Res. 2016 Jul;131:40–48.
   PubMed Web of Science ®Google Scholar
• Soussan P, Pol J, Garreau F, et al. Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease. J Infect Dis. 2008 Jul 15;198(2):218–225.
   PubMed Web of Science ®Google Scholar
• Günther S, Sommer G, Iwanska A, et al. Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology. 1997 Nov 24;238(2):363–371.
   PubMed Web of Science ®Google Scholar